MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE
    6.
    发明申请
    MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE 审中-公开
    改良抗炎蛋白及其使用方法

    公开(公告)号:US20160229905A1

    公开(公告)日:2016-08-11

    申请号:US15023165

    申请日:2014-09-18

    IPC分类号: C07K14/81 A61K45/06 A61K38/57

    摘要: A modified Ac-TMP-2 protein lacks one or a plurality of acidic C-terminal amino acids normally present in a full-length or wild-type Ac-TMP-2 protein and may also lack one or a plurality of N-terminal amino acids while retaining the amino acid sequence C—S—C at or near the N-terminus. The modified Ac-TMP-2 protein may be useful in method and composition for reducing or alleviating inflammation in a subject. Inflammation may be associated with a disease is a disease of the digestive tract such as chronic gastritis or an inflammatory bowel disease such as Crohn's disease or ulcerative colitis, or a disease of the respiratory system, such as asthma, emphysema, chronic bronchitis, and chronic obstructive pulmonary disease.

    摘要翻译: 改良的Ac-TMP-2蛋白缺乏通常存在于全长或野生型Ac-TMP-2蛋白质中的一个或多个酸性C末端氨基酸,并且也可能缺少一个或多个N-末端氨基 酸,同时保留N-末端或其附近的氨基酸序列C-S-C。 修饰的Ac-TMP-2蛋白可用于减少或减轻受试者的炎症的方法和组合物。 炎症可能与疾病相关,是消化道疾病,如慢性胃炎或炎症性肠病如克罗恩病或溃疡性结肠炎,或呼吸系统疾病,如哮喘,肺气肿,慢性支气管炎和慢性疾病 阻塞性肺疾病。

    MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE

    公开(公告)号:US20210061886A1

    公开(公告)日:2021-03-04

    申请号:US17071563

    申请日:2020-10-15

    摘要: A modified Ac-TMP-2 protein lacks one or a plurality of acidic C-terminal amino acids normally present in a full-length or wild-type Ac-TMP-2 protein and may also lack one or a plurality of N-terminal amino acids while retaining the amino acid sequence C-S-C at or near the N-terminus. The modified Ac-TMP-2 protein may be useful in method and composition for reducing or alleviating inflammation in a subject. Inflammation may be associated with a disease is a disease of the digestive tract such as chronic gastritis or an inflammatory bowel disease such as Crohn's disease or ulcerative colitis, or a disease of the respiratory system, such as asthma, emphysema, chronic bronchitis, and chronic obstructive pulmonary disease.